Aspira Pathlab Complete Financial Statements

In FY2025, Aspira Pathlab (ASPIRA) reported revenue ₹6 Cr, net profit ₹1 Cr and EPS ₹0.66, with a net profit margin of 16.7% and ROE of 8.3%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Aspira Pathlab share price today.

3 Years of Data
2025 - 2023

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 16.67% 2025 data
EBITDA Margin 16.67% 2025 data
Operating Margin 16.00% 2025 data
Return on Assets 5.56% 2025 data
Return on Equity 8.33% 2025 data

Balance Sheet Ratios

Current Ratio 1.67 2025 data
Equity Ratio 66.67% 2025 data
Asset Turnover 0.33 2025 data

ASPIRA Revenue, Net Profit & EBITDA — Year-on-Year Growth

ASPIRA YoY (Mar 2024 vs Mar 2025) — revenue +50.0%, net profit +200.0%, expenses +25.0%.

Revenue Growth
+50.0%
Year-over-Year
Net Profit Growth
+200.0%
Year-over-Year
Expense Growth
+25.0%
Year-over-Year
Assets Growth
+20.0%
Year-over-Year
Equity Growth
+20.0%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year

ASPIRA Income Statement — Revenue, EBITDA & Net Profit

Aspira Pathlab revenue ₹6 Cr, EBITDA ₹1 Cr, net profit ₹1 Cr, EPS ₹0.66 (2025) — net profit margin 16.7%. Explore Aspira Pathlab intrinsic price to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Jun 2023
Revenue 6 5 6 4 5 6 3
Expenses 5 5 5 4 4 5 3
EBITDA 1 1 1 0 0 1 0
Operating Profit Margin % 16.00% 13.00% 21.00% -5.00% 6.00% 11.00% -17.00%
Depreciation 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0
Profit Before Tax 1 0 1 -1 0 0 -1
Tax 0 0 0 0 0 0 0
Net Profit 1 0 1 -1 0 0 -1
Earnings Per Share (₹) 0.66 0.41 0.96 -0.49 0.05 0.30 -0.70

ASPIRA Balance Sheet — Assets, Liabilities & Shareholders' Equity

ASPIRA total assets ₹18 Cr, total equity ₹12 Cr, total liabilities ₹ Cr (2025) — ROE 8.3%.

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 18 15
Current Assets 5 4
Fixed Assets 7 7
Capital Work in Progress 0 0
Investments 0 0
Other Assets 11 8
LIABILITIES
Total Liabilities
Current Liabilities 3 3
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 12 10
Share Capital 10 10
Reserves & Surplus -3 -5

ASPIRA Cash Flow Statement — Operating, Investing & Financing

Aspira Pathlab operating cash flow ₹2 Cr, investing ₹0 Cr, financing ₹-1 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities 2 1
Investing Activities 0 0
Financing Activities -1 -1
Net Cash Flow 1 0